Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Surgical Oncology|April 30, 2024
Machine learning for predicting colon cancer recurrenceErkan Kayikcioglu, Arif Hakan Onder, Burcu Bacak, et al.
Journal of Cancer Research and Therapeutics|January 4, 2020
A diagnostic dilemma: A rare case of an ovarian carcinoma with signet ring cells hidden behind a substantial dermatomyositisAsim Armagan Aydin, Hulya Ayik, Arif Hakan Onder, et al.
Annals of Saudi Medicine|February 5, 2023
Factors associated with development of an acute ischemic event during hospitalization for COVID-19 in cancer and non-cancer patientsArif Hakan Onder, Aysegul Seremet Keskin, Kubra Demir Onder, et al.
Hepatology Forum|August 11, 2022
Analysis of socioeconomic status and other factors affecting patient-graft survival in patients undergoing liver transplantationArif Hakan Onder, Goksel Bengi, Mucahit Ozbilgin, et al.
Cureus|October 3, 2022
Role of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer in the COVID-19 PandemicElanur Karaman, Arife Ulas, Arif Hakan Onder, et al.
Cureus|November 11, 2024
Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic CancerAsim Armagan Aydin, Erkan Kayikcioglu, Ahmet Unlu, et al.
Expert Opinion on Drug Safety|July 1, 2025
Efficacy and safety of omitting 5-fluorouracil bolus in combination chemotherapy regimens for gastrointestinal cancers: a systematic review and meta-analysisYusuf Ilhan, Onur Yazdan Balcık, Elif Sahın, et al.
Oncology Research and Treatment|January 16, 2022
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter StudyMuhammed Mustafa Atci, Baran Akagunduz, Metin Demir, et al.
Journal of Chemotherapy (Florence, Italy)|February 17, 2022
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre studyMuhammed Mustafa Atci, Baran Akagunduz, Metin Demir, et al.
World Journal of Gastrointestinal Oncology|June 9, 2025
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancerYusuf Ilhan, Onur Yazdan Balcik, Halil Goksel Guzel, et al.
Pageof 2